Sparse Gene Coexpression Network Analysis Reveals EIF3J-AS1 as a Prognostic Marker for Breast Cancer

Figure 5

Prognostic potential of EIF3J-AS1 and LPP-AS2. (a) According to the Kaplan–Meier plot, patients with high EIF3J-AS1 expression have better overall survival. (b) Patients with high LPP-AS2 expression do not have different overall survival, compared to patients with low LPP-AS2 expression. (c) Patients with high EIF3J-AS1 expression have better relapse-free survival. (d) Patients with high LPP-AS2 expression have better relapse-free survival.

(a)

(b)

(c)

(d)